Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Franz

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Annals of the American Thoracic Society|November 10, 2020
Lymphangioleiomyomatosis Association with Underlying Genotype in Patients with Tuberous Sclerosis ComplexXinlun Tian, Jennifer E Glass, David J Kwiatkowski, et al.
Plos Genetics|November 6, 2015
Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional TestingMagdalena E Tyburczy, Kira A Dies, Jennifer Glass, et al.
The Journal of Pediatrics|June 11, 2017
Improvement in Renal Cystic Disease of Tuberous Sclerosis Complex After Treatment with Mammalian Target of Rapamycin InhibitorBrian J Siroky, Alexander J Towbin, Andrew T Trout, et al.
Epilepsia|May 5, 2018
Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizuresDavid N Franz, John A Lawson, Zuhal Yapici, et al.
Chest|April 8, 2009
Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosisLisa R Young, David N Franz, Preeti Nagarkatte, et al.
The New England Journal of Medicine|January 11, 2008
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosisJohn J Bissler, Francis X McCormack, Lisa R Young, et al.
Epilepsia|October 25, 2021
Adjunctive everolimus therapy for tuberous sclerosis complex-associated refractory seizures: Results from the postextension phase of EXIST-3David N Franz, John A Lawson, Zuhal Yapici, et al.
Epilepsia|May 9, 2007
Surgical outcome in tuberous sclerosis complex: a multicenter surveyDeepak Madhavan, Sarah Schaffer, Alexei Yankovsky, et al.
Journal of Neurosurgery. Pediatrics|November 1, 2014
Long-term outcomes of resective epilepsy surgery after invasive presurgical evaluation in children with tuberous sclerosis complex and bilateral multiple lesionsRavindra Arya, Jeffrey R Tenney, Paul S Horn, et al.
The Lancet. Child & Adolescent Health|September 1, 2018
Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trialPaolo Curatolo, David N Franz, John A Lawson, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Annals of the American Thoracic Society|November 10, 2020
Lymphangioleiomyomatosis Association with Underlying Genotype in Patients with Tuberous Sclerosis ComplexXinlun Tian, Jennifer E Glass, David J Kwiatkowski, et al.
Plos Genetics|November 6, 2015
Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional TestingMagdalena E Tyburczy, Kira A Dies, Jennifer Glass, et al.
The Journal of Pediatrics|June 11, 2017
Improvement in Renal Cystic Disease of Tuberous Sclerosis Complex After Treatment with Mammalian Target of Rapamycin InhibitorBrian J Siroky, Alexander J Towbin, Andrew T Trout, et al.
Epilepsia|May 5, 2018
Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizuresDavid N Franz, John A Lawson, Zuhal Yapici, et al.
Chest|April 8, 2009
Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosisLisa R Young, David N Franz, Preeti Nagarkatte, et al.
The New England Journal of Medicine|January 11, 2008
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosisJohn J Bissler, Francis X McCormack, Lisa R Young, et al.
Epilepsia|October 25, 2021
Adjunctive everolimus therapy for tuberous sclerosis complex-associated refractory seizures: Results from the postextension phase of EXIST-3David N Franz, John A Lawson, Zuhal Yapici, et al.
Epilepsia|May 9, 2007
Surgical outcome in tuberous sclerosis complex: a multicenter surveyDeepak Madhavan, Sarah Schaffer, Alexei Yankovsky, et al.
Journal of Neurosurgery. Pediatrics|November 1, 2014
Long-term outcomes of resective epilepsy surgery after invasive presurgical evaluation in children with tuberous sclerosis complex and bilateral multiple lesionsRavindra Arya, Jeffrey R Tenney, Paul S Horn, et al.
The Lancet. Child & Adolescent Health|September 1, 2018
Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trialPaolo Curatolo, David N Franz, John A Lawson, et al.
Pageof 5